Press Release | Surfix Diagnostics, the The Netherlands Cancer Institute and CRCbioscreen B.V. join forces to validate biomarkers for colorectal cancer screening > Amsterdam and Wageningen, Netherlands, July 10, 2024: Today, Surfix Diagnostics alongside the Netherlands Cancer Institute (NKI) and CRCbioscreen, announce a collaboration aimed at enhancing colorectal cancer (CRC) screening methods. This project is set to leverage Surfix Diagnostics’ advanced photonic diagnostic platform and novel biomarkerstargeting molecularly-defined high risk precursor lesions and cancer discovered by NKI. This project is, supported by a PPP grant from the @TKI-program Life Sciences & Health of Health~Holland International, marking a significant step forward in non-invasive colorectal cancer early detection. Read more > https://lnkd.in/gAsrsyHG
#screening #lifescience, #biomedical, #innovation, #healthcare, #detection, #biotechnology, #engineering, #biosensing
Bedankt voor de uitnodiging. Het was een mooi evenement.